Form 4: Encompass Health Director Boosts Stock Holdings

Encompass Health Corp. Director Christopher R. Reidy increased his beneficial ownership of common stock through RSU awards and a deferred stock investment plan.

Summary

• Christopher R. Reidy, a Director of Encompass Health Corp. (EHC), reported transactions on January 15, 2026.
• Reidy acquired 19 restricted stock units (RSUs) at a price of $0, which were credited to his account due to common stock dividend payments.
• The RSU award was calculated based on a $0.19 per share dividend and a closing price of $102.80 on the dividend payment date.
• He also acquired 346 shares of Encompass Health Common Stock at a weighted average price of $103.07 per share.
• These 346 shares were purchased through the Directors Deferred Stock Investment Plan, funded by deferred director fees and reinvested cash dividends.
• The purchase price for the 346 shares ranged from $102.79 to $103.08.
• Following these transactions, Reidy's direct beneficial ownership of Encompass Health Common Stock increased to 15,450 shares.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as a director's increased ownership, even through compensation mechanisms, generally indicates confidence in the company's value and future prospects. There are no negative aspects reported.

Positives

• A director increasing their stake in the company, even through compensation plans, can signal confidence in the company's future prospects.
• The existence of a Directors Deferred Stock Investment Plan and RSU awards aligns the interests of non-employee directors with those of shareholders.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on insider transactions.

Industry Context

This Form 4 filing represents a routine insider transaction, common across publicly traded companies, where a director increases their stake through compensation plans. It does not provide specific insights into broader industry trends or competitive landscape.

Corporate Governance

Related Party Transactions

• Acquisition of 19 restricted stock units (RSUs) by Director Christopher R. Reidy as part of an outstanding RSU award agreement, tied to common stock dividend payments.
• Purchase of 346 shares of common stock by Director Christopher R. Reidy through the company's Directors Deferred Stock Investment Plan, funded by deferred director fees and reinvested dividends.

Stakeholder Impact

• Shareholders: Increased director ownership may be viewed positively, signaling management's confidence in the company's performance and future value.

Key Dates

Recommendation

This Form 4 filing reports routine insider transactions related to director compensation and deferred investment plans. While director stock acquisition can be a positive signal, these transactions are part of a pre-established compensation structure rather than a discretionary open-market purchase based on new material information. Therefore, it does not provide sufficient new information to warrant a change from a 'hold' recommendation, which implies maintaining current positions while awaiting more substantial operational or financial updates.

Keywords

Encompass Health, EHC, Form 4, Insider Transaction, Director Stock Purchase, Restricted Stock Units, Dividend Reinvestment, Deferred Compensation